ASCL2 and pachyonychia congenita: Moreover, tRF-18-8R6546D2, a novel oncogenic factor, promotes PC malignancy partly by directly silencing achaete-scute homolog 2 (ASCL2) and further regulating its downstream genes such as MYC and CASP3 [100].